New Jersey Bariatric Center prescribes both, along with other FDA-approved options like Saxenda and Qsymia for those who qualify
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J
BPC 157 Peptides The Gut-Inflammation Connection BPC-157 reduces inflammatory cytokines throughout the gastrointestinal tract
This slower movement through the stomach gives your brain more time to register fullness, reducing overall calorie intake
none of it constitutes a therapeutic claim for human use
"Compounded drugs can be important for overcoming shortages or meeting unique patient needs - but compounders should not try to compound drugs in a way that circumvents [the] FDA's approval process." Under US regulations, compounding pharmacies can make and sell medicines - even if they are still under patent - if supplies are limited in the marketplace